Jones Financial Companies
ALT icon

Jones Financial Companies’s Altimmune ALT Stock Holding History

Jones Financial Companies’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.1K Buy
25,869
+13,343
+107% +$56.7K ﹤0.01% 2769
2025
Q4 		$45.2K Buy
12,526
+5,900
+89% +$25.7K ﹤0.01% 2575
2025
Q3 		$26.5K Hold
6,626
– – ﹤0.01% 2653
2025
Q2 		$23.2K Buy
6,626
+993
+18% +$5.37K ﹤0.01% 2529
2025
Q1 		$30K Buy
+5,633
New +$35.7K ﹤0.01% 2272

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jones Financial Companies's ALT Position: Q1 2026 in Review

Jones Financial Companies increased its Altimmune (ALT) stake by 107% in Q1 2026, buying an estimated $56.7K and bringing the position to 25,869 shares worth $78.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

Jones Financial Companies first reported a position in ALT in Q1 2025 and has held it in 5 quarters since. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Jones Financial Companies held 25,869 shares of Altimmune worth $78.1K as of Q1 2026.
  • Jones Financial Companies bought 13,343 Altimmune shares in Q1 2026, an estimated $56.7K.
  • Altimmune made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #2769 holding.
  • Jones Financial Companies first reported a position in Altimmune in Q1 2025 and has held it in 5 quarters since.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.